# EDGAR Filing Document

**Accession Number:** 0001669504
**File Stem:** 0001669504-26-000003
**Filing Date:** 2026-2
**Character Count:** 11970
**Document Hash:** 9ac8c750e7ff0f988e296392c19f6f60
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001669504-26-000003.hdr.sgml**: 20260202

**ACCESSION NUMBER**: 0001669504-26-000003

**CONFORMED SUBMISSION TYPE**: D/A

**PUBLIC DOCUMENT COUNT**: 1

**ITEM INFORMATION**: Rule 506(b) provides a "safer harbor" for a private offering

**ITEM INFORMATION**: Investment Company Act Section 3(c)

**ITEM INFORMATION**: Section 3(c)(1)

**FILED AS OF DATE**: 20260202

**DATE AS OF CHANGE**: 20260130

**EFFECTIVENESS DATE**: 20260202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Misaki Engagement Fund II Ltd
- **CENTRAL INDEX KEY:** 0001669504

**ORGANIZATION NAME:**
- **EIN:** 981293201
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** D/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 021-259558
- **FILM NUMBER:** 26585009

**BUSINESS ADDRESS:**
- **STREET 1:** C/O MISAKI CAPITAL INC.
- **STREET 2:** 1-4-1 MARUNOUCHI
- **CITY:** CHIYODA-KU, TOKYO
- **STATE:** M0
- **ZIP:** 100-0005
- **BUSINESS PHONE:** 81-3-6427-7431

**MAIL ADDRESS:**
- **STREET 1:** C/O MISAKI CAPITAL INC.
- **STREET 2:** 1-4-1 MARUNOUCHI
- **CITY:** CHIYODA-KU, TOKYO
- **STATE:** M0
- **ZIP:** 100-0005

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM D

### Notice of Exempt Offering of Securities

**Notice of Amendment** (Previous Accession Number: 0001669504-25-000002)

### 1. Issuer's Identity

**CIK (Filer ID Number):** 0001669504

**Name of Issuer:** Misaki Engagement Fund II Ltd

**Jurisdiction of Incorporation/Organization:** CAYMAN ISLANDS

**Previous Names:** None

**Year of Incorporation/Organization**

- [x] Over Five Years Ago

- [ ] Within Last Five Years (Specify Year)

- [ ] Yet to Be Formed

**Entity Type**

- [ ] Corporation

- [ ] Limited Partnership

- [ ] Limited Liability Company

- [ ] General Partnership

- [ ] Business Trust

- [x] Other (An exempted company incorporated under the laws of the Cayman Islands.)

### 2. Principal Place of Business and Contact Information

**Name of Issuer:** Misaki Engagement Fund II Ltd

**Street Address 1:** C/O MISAKI CAPITAL INC.

**Street Address 2:** 1-4-1 MARUNOUCHI

**City:** CHIYODA-KU, TOKYO

**State/Province/Country:** M0

**ZIP/Postal Code:** 100-0005

**Phone Number of Issuer:** 81-3-6427-7431

### 3. Related Persons

| Last Name           | First Name       | Street Address 1                  | City              | State   | ZIP/Postal Code   | Relationship                                          | Clarification of Response                                                           |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Misaki Capital Inc. | N/A              | 1-4-1 Marunouchi                  | Tokyo             | M0      | 100-0005          | [ ] Executive Officer<br>[ ] Director<br>[x] Promoter | The Investment Manager of the Issuer.                                               |
| Kobayashi           | Masato           | 6-7-14-1005 Akasaka               | Tokyo             | M0      | 107-0052          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter |  |
| Aso                 | Takeo            | c/o Misaki Capital Inc.           | Chiyoda-ku, Tokyo | M0      | 100-0005          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Mr. Aso is also a Chief Investment Officer of the Investment Manager of the Issuer. |
| Fox                 | Adam             | c/o Ogier Global (Cayman) Limited | Grand Cayman      | E9      | KY1-9009          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter |  |
| Gillooly            | Benjamin Michael | c/o Ogier Global (Cayman) Limited | Grand Cayman      | E9      | KY1-9009          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter |  |

### 4. Industry Group

| | | |
|:---|:---|:---|
| [ ] Agriculture | [ ] Health Care | [ ] Retailing |
| [ ] Banking & Financial Services | [ ] Biotechnology | [ ] Restaurants |
|   [ ] Commercial Banking | [ ] Health Insurance | [ ] Technology |
|   [ ] Insurance | [ ] Hospitals & Physicians |   [ ] Computers |
|   [ ] Investing | [ ] Pharmaceuticals |   [ ] Telecommunications |
|   [ ] Investment Banking | [ ] Other Health Care |   [ ] Other Technology |
|   [x] Pooled Investment Fund | [ ] Manufacturing | [ ] Travel |
|     [x] Hedge Fund | [ ] Real Estate |   [ ] Airlines & Airports |
|     [ ] Private Equity Fund |   [ ] Commercial |   [ ] Lodging & Conventions |
|     [ ] Venture Capital Fund |   [ ] Construction |   [ ] Tourism & Travel Services |
|     [ ] Other Investment Fund |   [ ] REITS & Finance |   [ ] Other Travel |
|   Is the issuer registered as an investment company? <br>  [ ] Yes [x] No |   [ ] Residential | [ ] Other |
|   [ ] Other Banking & Financial Services |   [ ] Other Real Estate |  |
| [ ] Business Services |  |  |
| [ ] Energy |  |  |
|   [ ] Coal Mining |  |  |
|   [ ] Electric Utilities |  |  |
|   [ ] Energy Conservation |  |  |
|   [ ] Environmental Services |  |  |
|   [ ] Oil & Gas |  |  |
|   [ ] Other Energy |  |  |

### 5. Issuer Size

| **Revenue Range** | **OR** | **Aggregate Net Asset Value Range** |
|:---|:---:|:---|
| [ ] No Revenues | | [ ] No Aggregate Net Asset Value |
| [ ] $1 - $1,000,000 | | [ ] $1 - $5,000,000 |
| [ ] $1,000,001 - $5,000,000 | | [ ] $5,000,001 - $25,000,000 |
| [ ] $5,000,001 - $25,000,000 | | [ ] $25,000,001 - $50,000,000 |
| [ ] $25,000,001 - $100,000,000 | | [ ] $50,000,001 - $100,000,000 |
| [ ] Over $100,000,000 | | [ ] Over $100,000,000 |
| [ ] Decline to Disclose | | [x] Decline to Disclose |
| [ ] Not Applicable | | [ ] Not Applicable |

### 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

| | | |
|:---|:---|:---|
| [ ] Rule 504(b)(1) (not (i), (ii) or (iii)) | [x] Investment Company Act Section 3(c) |  |
| [ ] Rule 504(b)(1)(i) |   [x] Section 3(c)(1) |  |
| [ ] Rule 504(b)(1)(ii) |   [ ] Section 3(c)(2) |   [ ] Section 3(c)(9) |
| [ ] Rule 504(b)(1)(iii) |   [ ] Section 3(c)(3) |   [ ] Section 3(c)(10) |
| [x] Rule 506(b) |   [ ] Section 3(c)(4) |   [ ] Section 3(c)(11) |
| [ ] Rule 506(c) |   [ ] Section 3(c)(5) |   [ ] Section 3(c)(12) |
| [ ] Securities Act Section 4(5) |   [ ] Section 3(c)(6) |   [ ] Section 3(c)(13) |
|  |   [ ] Section 3(c)(7) |   [ ] Section 3(c)(14) |

### 7. Type of Filing

**New Notice:** [ ] **Date of First Sale:** 2016-03-01

**Amendment:** [x]

### 8. Duration of Offering

Does the issuer intend this offering to last more than one year? [x] Yes [ ] No

### 9. Type(s) of Securities Offered

- [ ] Equity
- [ ] Debt
- [ ] Option, Warrant or Other Right to Acquire Another Security
- [ ] Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
- [x] Pooled Investment Fund Interests
- [ ] Tenant-in-Common Securities
- [ ] Mineral Property Securities
- [x] Other (Classes G, H, and I Shares. The minimum amount reflected in Item 11 may be reduced or waived by the Directors of the Issuer.)

### 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? [ ] Yes [x] No

### 11. Minimum Investment
**Minimum investment accepted from any outside investor:** $1000000 USD

### 12. Sales Compensation

| Recipient Name                        |   Recipient CRD Number | Associated BD Name   | Associated BD CRD Number   | Street 1                    | Street 2   | City     | State   | ZIP Code   | States of Solicitation   | Foreign Solicitation   |
|:---|---:|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| James Han (Silver Leaf Partners, LLC) |                 126694 | None                 | None                       | 3 Columbus Circle, Floor 15 |  | New York | NY      | NY 10019   | All States               | [ ]                    |

### 13. Offering and Sales Amounts

**Total Offering Amount:** $5,000,000,000 USD

**Total Amount Sold:** $13,650,715 USD

**Total Remaining to be Sold:** $4,986,349,285 USD

**Clarification of Response:** The Total Amount Sold and the Number of Investors reflect sales to only US Investors.  Redemptions and/or withdrawals are not taken into consideration.

### 14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering: [ ] Yes [x] No

**Total Number of Investors Already Invested:** 7

### 15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

**Sales Commissions** $0 USD

**Finders' Fees** $0 USD

### 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters: **$0 USD [x] Estimate**

**Clarification of Response (if necessary):** Certain persons named in Item 3 or affiliates thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time.

### Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

**Terms of Submission**

In submitting this notice, each issuer named above is:

* Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.

* Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated
officer of the State in which the issuer maintains its principal place of business and any State in which this notice is
filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any
notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any
Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to
the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in
connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or
indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust
Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or
regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place
of business or any State in which this notice is filed.

* Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

| Issuer                        | Signature   | Name of Signer   | Title                  | Date       |
|:---|:---|:---|:---|:---|
| Misaki Engagement Fund II Ltd | Takeo Aso   | Takeo Aso        | Director of the Issuer | 2026-01-30 |

*Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.*